eHealth’s second quarter saw revenue exceed Wall Street’s expectations, with the market reacting positively to the company’s ability to adapt in a challenging environment. Management attributed this performance to stronger-than-anticipated Medicare Advantage enrollments and improved member retention, which drove favorable tail revenue and lifetime value metrics. CEO Fran Soistman noted that the company navigated regulatory changes limiting dual-eligible enrollments by shifting focus to insurance products that can be sold year-round and by implementing operational adjustments within the telesales organization. Soistman highlighted, “We successfully navigated benefit plan cancellations and carrier market exits, which enabled us to continue offering high-quality plan options across all of our key markets.”
Is now the time to buy EHTH? Find out in our full research report (it’s free).
eHealth (EHTH) Q2 CY2025 Highlights:
- Revenue: $60.78 million vs analyst estimates of $46.41 million (7.7% year-on-year decline, 31% beat)
- Adjusted EPS: -$0.80 vs analyst estimates of -$1.25 (35.9% beat)
- Adjusted EBITDA: -$14.14 million vs analyst estimates of -$34.92 million (-23.3% margin, 59.5% beat)
- The company lifted its revenue guidance for the full year to $545 million at the midpoint from $530 million, a 2.8% increase
- EBITDA guidance for the full year is $65 million at the midpoint, above analyst estimates of $51.68 million
- Operating Margin: -37.9%, up from -42.5% in the same quarter last year
- Estimated Membership: 1.15 million, down 31,137 year on year
- Market Capitalization: $105.7 million
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From eHealth’s Q2 Earnings Call
- George Frederick Sutton (Craig-Hallum) sought clarification on why improved broker commission rates for 2026 are not yet included in guidance. CEO Fran Soistman explained the company is awaiting greater visibility from carrier discussions before updating forecasts.
- George Frederick Sutton (Craig-Hallum) asked about the scope and function of the AI voice agent pilot. Soistman detailed that AI agents handle initial customer data gathering and then transfer calls to licensed advisers, improving answer rates and customer experience.
- George Frederick Sutton (Craig-Hallum) requested more detail on capital structure plans, including the handling of the term loan and convertible securities. Soistman clarified that efforts focus first on refinancing the term loan and increasing liquidity, with the commissions receivable asset playing a central role.
- Leslie (Deutsche Bank, for George Hill) questioned how anticipated Medicare Advantage benefit reductions will impact market growth and churn. Soistman said the upcoming AEP is likely to resemble last year’s, with both benefit and service area changes, but noted carriers must still pursue growth in profitable markets.
- Leslie (Deutsche Bank, for George Hill) asked about the future of ACA plan subsidies and regulatory oversight. Soistman expressed confidence that some level of subsidization will continue, and highlighted that market disruption could increase demand for eHealth’s guidance services.
Catalysts in Upcoming Quarters
Looking ahead, the StockStory team will focus on (1) how effectively eHealth navigates Medicare AEP disruptions and leverages its broad carrier relationships, (2) the impact of AI and technology-driven enhancements on call center productivity and member retention, and (3) execution of capital structure initiatives to maintain financial flexibility. Developments in regulatory policy and carrier strategies will also be critical to monitor.
eHealth currently trades at $3.49, up from $3.26 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).
High-Quality Stocks for All Market Conditions
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
